GRAL241115P5000
- 0.00
- 0.000.00%
Grail Newsroom
GRAIL to Announce Third Quarter 2024 Financial Results
Express News | Grail Presents Initial Results From Reflection Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (Mced) Test at the Early Detection of Cancer Conference
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference
Express News | Grail Appoints Sarah Krevans to Board of Directors
Press Release: GRAIL Appoints Sarah Krevans to Board of Directors
GRAIL CEO & Director Robert Ragusa Sells 51% Of Holding
GRAIL Analyst Ratings
Guggenheim Initiates Grail(GRAL.US) With Hold Rating
Grail Initiated With a Neutral at Guggenheim
12 Health Care Stocks Moving In Monday's After-Market Session
GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now
Grail Inc. Executive Acquires Over $1 Million in Company Stock
Vieu Cracks the "Holy Grail" of B2B Sales With AI-powered Business Network; Raises $11m as Growth Scales
We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate
Why a Roth IRA Is the 'Holy Grail' Retirement Account—no Matter Your Income
Regulatory milestone event! The court ruled that the European Commission exceeded its authority in the Illumina (ILMN.US)-Grail (GRAL.US) acquisition case.
In the litigation over the Grail acquisition trade case with the European Commission, the European Union's highest court ruled in favor of Illumina.
*EU Court Ruling Set to Curb Antitrust Enforcers' Powers in Reviewing Small Takeovers -- WSJ
EU Top Court Backs Illumina Fight Against EU Probe Into Grail Deal
Express News | Illumina Wins Court Fight Against EU Power to Examine Grail Deal
Express News | Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)